1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Analysis of the US Immunochemistry Market

Analysis of the US Immunochemistry Market

  • October 2014
  • -
  • Frost & Sullivan
  • -
  • 88 pages

Clinicians Will Likely Opt for Integrated Analyzers over Standalone Clinical and Immunoassay Analyzers in the Next 2 Years

This study provides trends in the US immunochemistry market and the clinical chemistry market. The install base of analyzer models from top vendors are projected from 2012 and 2013, and resulting trends have been studied. The study includes list prices of analyzers, analytes detected, and average discounts offered. Customer segmentation includes various analyzers from vendors such as Abbott Diagnostics, Siemens Healthcare, Roche Diagnostics, Phadia (Thermo Fisher Scientific), Alere, Inova Diagnostics, Tosoh Bioscience, bioMérieux, DiaSorin, Bio-Rad, IDS, Ortho-Clinical Diagnostics, Awareness Technology, The Binding Site, and Beckman Coulter.

Executive Summary—Key Findings
-The US immunochemistry market generated $ million in 2013 and is expected to grow at a compound annual growth rate (CAGR) of% from 2013 to 2015. The market comprises the sales of analyzers and reagents. The US immunochemistry market represents % of the US in vitro diagnostics (IVD) market.
-The immunochemistry market is heavily impacted by rapid replacement trends, which affect the clinical chemistry market. The clinical chemistry market contributed % of the US IVD market. The US clinical chemistry market generated $ million in 2013 and is expected to grow at a CAGR of % from 2013 to 2015.
-In terms of technology trends, the market is increasingly seeing the entry of chemiluminescence immunoassay (CLIA) systems, which are replacing older versions. Smaller labs still opt for fluorescent immunoassay (FIA) systems or semi-automated CLIA systems. Enzyme-linked immunosorbent assay (ELISA) systems and open systems are exhibiting some growth because of their open platform capabilities and larger test menu and affordability. FIA and CLIA systems tend to be more expensive. which works in favor of ELISA systems.
-Frost & Sullivan, however, estimates that ELISA systems will eventually experience erosion because of their lack of sensitivity and low specificities, especially as most laboratories are now consolidating and converting to high throughput systems. As a result, many vendors are using this opportunity to offer immunoassay or standalone clinical chemistry systems for a high discounted price. Demand for immunochemistry systems seems to work negatively for vendors. Because of this, the retention of the install base is crucial. Some strategies adopted by vendors include offering large discounts/upgrades, adding automation capabilities to existing modules, and having long reagent rental contracts.
-Frost & Sullivan’s install base analysis reveals that a few open system platforms are declining in their install base, leading to rapid transition to either an FIA or a CLIA system.
-Dominating vendors are Roche Diagnostics, Siemens Healthcare Diagnostics, and Abbott Diagnostics. The US immunochemistry market is seeing the influx of many newer companies from Canada, Japan, China, and Europe. The market has undergone a massive change from a handful of participants offering only ELISA, CLIA, radioimmunoassay (RIA), and FIA as well as multiparametric assays such as microarrays, flow cytometry-based platforms, recombinant immunoassays, and indirect immunofluorescence assays (IFA).

Table Of Contents

Analysis of the US Immunochemistry Market
1. EXECUTIVE SUMMARY

Executive Summary
Executive Summary—Key Findings
Key Companies to Watch

2. METHODOLOGY

Methodology

3. MARKET DEFINITIONS AND OVERVIEW

Market Definitions and Overview
Market Definitions
Market Overview
Market Challenges
Product Segment Trends
Possible Areas of Growth for Immunochemistry Assays
Current Market Participant Strategies
Competitive Factors
Current and Future Landscape

4. REVENUE FORECAST—IMMUNOCHEMISTRY MARKET

Revenue Forecast—Immunochemistry Market
Revenue Forecast—Clinical Chemistry Market
Revenue Discussion

5. INSTALL BASE ANALYSIS BY MANUFACTURER AND MODEL—ROCHE DIAGNOSTICS

Install Base Analysis by Manufacturer and Model—Roche Diagnostics
OEM—Roche Diagnostics

6. THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific
OEM—Thermo Fisher Scientific

7. ABBOTT DIAGNOSTICS

Abbott Diagnostics
OEM—Abbott Diagnostics

8. TOSOH BIOSCIENCE

Tosoh Bioscience
OEM—Tosoh Bioscience

9. BECKMAN COULTER

Beckman Coulter
OEM—Beckman Coulter

10. SIEMENS HEALTHCARE DIAGNOSTICS

Siemens Healthcare Diagnostics
OEM—Siemens Healthcare Diagnostics

11. BIOMÉRIEUX AND DIASORIN

bioMerieux and DiaSorin
OEM—bioMerieux and DiaSorin

12. BIO-RAD, INOVA DIAGNOSTICS, AND IDS

Bio-Rad, Inova Diagnostics, and IDS
OEM—Bio-Rad, Inova Diagnostics, and Instant Diagnostic Systems (IDS)

13. ORTHO-CLINICAL DIAGNOSTICS, INC.

Ortho-Clinical Diagnostics, Inc.
OEM—Ortho-Clinical Diagnostics

14. AWARENESS TECHNOLOGY, ALERE, AND THE BINDING SITE

Awareness Technology, Alere, and The Binding Site
OEMAwareness Technology, Alere, and The Binding Site

15. CUSTOMER SEGMENT FOCUS

Customer Segment Focus
Comparative Analysis of Competitor Coverage

16. PRICING AND DISCOUNTS

Pricing and Discounts

17. STRATEGIC RECOMMENDATIONS

Strategic Recommendations

18. THE LAST WORD

The Last Word
Legal Disclaimer

19. THE FROST and SULLIVAN STORY

The Frost and Sullivan Story
Value Proposition: Future of Your Company and Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.